$ASST
Asset Entities Inc.

2023 Q1 Form 10-Q Financial Statement

#000121390023038555 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $61.14K $62.97K $126.1K
YoY Change -51.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.132M $295.2K
YoY Change
% of Gross Profit
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $1.132M $295.2K $210.3K
YoY Change 438.57%
Operating Profit -$1.071M -$84.20K
YoY Change 1172.27%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.071M -$232.3K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$1.071M -$232.3K -$84.20K
YoY Change 1172.27%
Net Earnings / Revenue -1752.27% -368.84% -66.79%
Basic Earnings Per Share -$0.09 -$0.01
Diluted Earnings Per Share -$0.09 -$0.05 -$0.01
COMMON SHARES
Basic Shares Outstanding 12.46M shares 10.00M shares
Diluted Shares Outstanding 12.46M shares 10.00M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.922M $137.2K
YoY Change
Cash & Equivalents $5.922M $137.2K $33.65K
Short-Term Investments
Other Short-Term Assets $86.43K $235.8K
YoY Change
Inventory
Prepaid Expenses $86.43K
Receivables $2.995K
Other Receivables $0.00
Total Short-Term Assets $6.012M $373.0K
YoY Change 535.13%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $6.012M $373.0K
Total Long-Term Assets $0.00 $0.00
Total Assets $6.012M $373.0K
YoY Change 535.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue $4.045K $4.648K
YoY Change -27.94%
Short-Term Debt $184.5K $214.6K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $188.5K $219.2K
YoY Change 1305.91%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $188.5K $219.2K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $188.5K $219.2K
YoY Change 1305.91%
SHAREHOLDERS EQUITY
Retained Earnings -$1.698M -$627.1K
YoY Change -3557.67%
Common Stock $7.520M $779.8K
YoY Change 211.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.823M $153.8K $33.94K
YoY Change
Total Liabilities & Shareholders Equity $6.012M $373.0K
YoY Change 535.13%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.071M -$232.3K -$84.20K
YoY Change 1172.27%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$829.9K -$209.6K -$75.08K
YoY Change 1005.46%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $6.615M 329.9K $75.00K
YoY Change 8720.16%
NET CHANGE
Cash From Operating Activities -$829.9K -209.6K -$75.08K
Cash From Investing Activities
Cash From Financing Activities $6.615M 329.9K $75.00K
Net Change In Cash $5.785M 120.3K -$77.00
YoY Change -7513312.99%
FREE CASH FLOW
Cash From Operating Activities -$829.9K -$209.6K -$75.08K
Capital Expenditures
Free Cash Flow -$829.9K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-41612
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1293236
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Crescent Ct
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
7th Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
CY2023Q1 dei City Area Code
CityAreaCode
(214)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
459-3117
CY2023Q1 dei Security12b Title
Security12bTitle
Class B Common Stock, $0.0001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
ASST
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5922351 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137177 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2995 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
86432 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
235844 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
6011778 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
373021 usd
CY2023Q1 us-gaap Assets
Assets
6011778 usd
CY2022Q4 us-gaap Assets
Assets
373021 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
184498 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
214590 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4045 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4648 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
188543 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
219238 usd
CY2023Q1 us-gaap Liabilities
Liabilities
188543 usd
CY2022Q4 us-gaap Liabilities
Liabilities
219238 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 asst Common Stock Value One
CommonStockValueOne
839 usd
CY2022Q4 asst Common Stock Value One
CommonStockValueOne
839 usd
CY2023Q1 asst Common Stock Value2
CommonStockValue2
527 usd
CY2022Q4 asst Common Stock Value2
CommonStockValue2
236 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7520238 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
779826 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1698369 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-627118 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5823235 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
153783 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6011778 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
373021 usd
CY2023Q1 us-gaap Revenues
Revenues
61135 usd
CY2022Q1 us-gaap Revenues
Revenues
126059 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
36581 usd
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
30795 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
345941 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
120610 usd
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
749864 usd
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
58854 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1132386 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
210259 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1071251 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-84200 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071251 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-84200 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12464256 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10000000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
153783 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6540493 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
200210 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071251 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5823235 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
43137 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
75000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-84200 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
33937 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071251 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-84200 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
200210 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2995 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4250 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
86432 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
131125 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8145 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-603 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5228 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-829946 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75077 usd
CY2023Q1 asst Conversion From Class A To Class B Common Stock
ConversionFromClassAToClassBCommonStock
6615120 usd
CY2022Q1 asst Conversion From Class A To Class B Common Stock
ConversionFromClassAToClassBCommonStock
75000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6615120 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
75000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5785174 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-77 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137177 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33731 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5922351 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33654 usd
CY2022Q1 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
250000000 shares
CY2022Q1 us-gaap Other Ownership Interests Units Outstanding
OtherOwnershipInterestsUnitsOutstanding
51250000 shares
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1698369 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1071251 usd
CY2023Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
6600000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in; text-align: justify"> </p>
CY2023Q1 us-gaap Derivative Cash Received On Hedge
DerivativeCashReceivedOnHedge
250000 usd
CY2023Q1 asst Amount Excess
AmountExcess
5700000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7995 usd
CY2023Q1 us-gaap Cash Flow Hedge Derivative Instrument Liabilities At Fair Value
CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue
5000 usd
CY2023Q1 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
4045 usd
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
4648 usd
CY2022Q1 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
51250000 shares
CY2023Q1 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
8385276 shares
CY2022 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
8385276 shares
CY2023Q1 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
884880 usd
CY2023Q1 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
6615120 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
1411000 shares
CY2023Q1 us-gaap Receivable From Officers And Directors For Issuance Of Capital Stock
ReceivableFromOfficersAndDirectorsForIssuanceOfCapitalStock
3428730 usd
CY2023Q1 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
5275724 shares
CY2022Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
2364724 shares
CY2023Q1 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
105000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
105000 shares
CY2023Q1 us-gaap Shares Acquired Weighted Average Discount To Net Assets Percentage
SharesAcquiredWeightedAverageDiscountToNetAssetsPercentage
0.07 pure
CY2023Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
6.25
CY2023Q1 asst Public Offering Price Percentage
PublicOfferingPricePercentage
1.25 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
52500 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M4D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
105000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.25
CY2023Q1 asst Weighted Average Lifeyears Granted
WeightedAverageLifeyearsGranted
P5Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
157500 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y8M19D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q1 us-gaap Insurance Agency Management Fee
InsuranceAgencyManagementFee
749864 usd
CY2022Q1 us-gaap Insurance Agency Management Fee
InsuranceAgencyManagementFee
58854 usd
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Asset Entities Inc.
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q1 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10000000 shares
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001920406

Files In Submission

Name View Source Status
0001213900-23-038555-index-headers.html Edgar Link pending
0001213900-23-038555-index.html Edgar Link pending
0001213900-23-038555.txt Edgar Link pending
0001213900-23-038555-xbrl.zip Edgar Link pending
asst-20230331.xsd Edgar Link pending
f10q0323ex31-1_assetentities.htm Edgar Link pending
f10q0323ex31-2_assetentities.htm Edgar Link pending
f10q0323ex32-1_assetentities.htm Edgar Link pending
f10q0323ex32-2_assetentities.htm Edgar Link pending
f10q0323_assetent.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
asst-20230331_cal.xml Edgar Link unprocessable
asst-20230331_def.xml Edgar Link unprocessable
asst-20230331_lab.xml Edgar Link unprocessable
asst-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0323_assetent_htm.xml Edgar Link completed